PTIX Return on Tangible Equity | Protagenic Therapeutics, Inc.\new

Protagenic Therapeutics, Inc.\new (PTIX) Return on Tangible Equity

2026-06-30: Return Tang Equity -1532.09%.
2026-03-31: Return Tang Equity 260.24%.
2025-12-31: Return Tang Equity 123.74%.
2025-09-30: Return Tang Equity 126.76%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-1532.09%
2026-03-31	260.24%
2025-12-31	123.74%
2025-09-30	126.76%
2025-06-30	209.49%
2025-03-31	72.52%
2024-12-31	104.92%
2024-09-30	174.34%
2024-06-30	292.12%
2024-03-31	335.73%
2023-12-31	-136.32%
2023-09-30	-94.54%
2023-06-30	-63.81%
2023-03-31	-45.39%
2022-12-31	-51.40%
2022-09-30	-52.08%
2022-06-30	-45.99%
2022-03-31	-53.66%
2021-12-31	-45.49%
2021-09-30	40.08%
2021-06-30	-40.04%
2021-03-31	164.26%
2020-12-31	221.68%
2020-09-30	271.86%
2020-06-30	281.01%
2020-03-31	281.65%
2019-12-31	276.01%
2019-09-30	492.31%
2019-06-30	570.50%
2019-03-31	707.15%
2018-12-31	1212.77%
2018-09-30	-762.77%
2018-06-30	-432.42%
2018-03-31	-228.00%
2017-12-31	-185.32%
2017-09-30	-125.95%
2017-06-30	-112.99%
2017-03-31	-100.80%
2016-12-31	-91.88%
2016-09-30	-73.40%
2016-06-30	-67.18%
2016-03-31	-57.20%
2015-12-31	153.39%
2015-09-30	114.55%
2015-06-30	78.86%
2015-03-31	98.39%
2014-12-31	267.29%
2014-09-30	600.00%
2014-06-30	5142.86%
2013-12-31	7274.11%

Annual Return Tang Equity

Date	Return Tang Equity
2026-03-31	260.24%
2025-03-31	72.52%
2024-12-31	-545.36%
2023-12-31	-136.32%
2022-12-31	-51.40%
2021-12-31	-45.49%
2020-12-31	221.68%
2019-12-31	276.01%
2018-12-31	1212.77%
2017-12-31	-185.32%
2016-12-31	-91.88%
2015-12-31	153.39%
2015-06-30	95.77%
2014-06-30	5138.10%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Decoy Therapeutics Inc. (DCOY)	United States	$0.002B	-0.27
Nexentis Technologies Inc. (NXTS)		$0.002B
ORAGENICS INC (OGEN)	United States	$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)	United States	$0.002B	-0.02
BioXcel Therapeutics, Inc. (BTAI)	United States	$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)	United States	$0.002B
CDT Equity Inc. (CDT)	United States	$0.000B	-0.01
Matinas BioPharma Holdings, Inc. (MTNB)	United States	$0.003B
Aditxt, Inc. (ADTX)	United States	$0.000B
Rafael Holdings, Inc. (RFL)	United States	$0.000B	-0.00